PMI considers restarting production in Ukraine

May.24.2023
PMI considers restarting production in Ukraine
Philip Morris International considers restarting production in Ukraine despite security concerns and decreased sales.

In a recent interview with Interfax Ukraine, Massimo Andolina, the European Regional President of Philip Morris International (PMI), discussed the impact of Russia's invasion on multinational corporations in Ukraine. Andolina stated that PMI is exploring plans to restore production in Ukraine.


PMI has ceased production at its factory in Kharkiv due to ongoing security concerns resulting from the ongoing conflict. Currently, the company's brands in Ukraine are being temporarily produced by Imperial Tobacco. However, PMI intends to establish its own production facility in Ukraine.


Maximo Andolina emphasized two reasons for the decision: first, the desire to produce PMI's own products locally, and secondly, the company's commitment to investing in Ukraine even during times of war. He stated that PMI is actively exploring various alternative options for establishing new production facilities and plans to make relevant announcements in the near future.


The interview also touched on the decrease in PMI sales in the Ukrainian market. Massimo Andolina mentioned two factors: some people leaving the country or residing in occupied territory, resulting in consumer loss, and competition from illegal products. He stated that PMI has discussed with the government to address this issue and expressed confidence in the government's commitment to combating corruption and criminal activity. The company expects significant progress in combating illegal trade in the coming years.


Maximo Adonilna also shared his opinion on the government's decision to tax cigarettes and heated non-burning products. He stated that PMI believes these products should be considered different categories and taxed accordingly. They have noticed the success of heated tobacco products in the Ukrainian market and emphasized the necessity for differentiated tax treatment.


During the interview, the position of PMI in Russia was also addressed. According to Massimo Andolina, the company's top priority during the war was the protection of its Ukrainian employees' safety. Therefore, they temporarily suspended their investments in Russia and reduced their business operations. Despite PMI's previous announcement of its intention to withdraw from the Russian market, the changing regulatory environment has made it challenging for the company, which has significant business and assets in the country, to do so.


Reference List:


PMI is considering restarting production in Ukraine.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
On March 13, 2026, R.J. Reynolds and related companies filed an appeal with the U.S. Court of Appeals for the Federal Circuit, seeking review of the U.S. International Trade Commission’s final ruling in the disposable vape Section 337 investigation.
Mar.16 by 2FIRSTS.ai
AIR Expects to Complete CAEP Business Combination in Q2 2026 and List on Nasdaq
AIR Expects to Complete CAEP Business Combination in Q2 2026 and List on Nasdaq
AIR Limited and Cantor Equity Partners III announced that the F-4 registration statement related to their proposed business combination was declared effective by the U.S. Securities and Exchange Commission on April 22, 2026. Under the arrangement first announced on Nov. 7, 2025, the combined company, AIR Global PLC, is intended to list on Nasdaq in the United States under the ticker “AIIR.”
Apr.24 by 2FIRSTS.ai
Dutch Data Show 244 Companies Continued Illegal Vape Sales After Two Fines
Dutch Data Show 244 Companies Continued Illegal Vape Sales After Two Fines
According to RTL Nieuws, citing figures from the Netherlands Food and Consumer Product Safety Authority (NVWA), hundreds of Dutch shops continue to sell illegal vapes, often even after repeated fines.
Apr.08 by 2FIRSTS.ai
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai